Demant released a trading update on Oct. 9, 2026, citing strong US sales of its newly launched Oticon Zeal product, and announced a DKK 3 billion share buyback program through 2027. Shares rose 6% on the day.
Demant’s strong product pipeline, led by the global rollout of Oticon Zeal in 2026, will likely result in above-market growth in the next few years.
Demant has underperformed Sonova over the last two years in hearing aids. Sonova was the first to introduce real-time AI implementation, taking share from Demant.
|
Metric
|
DEMANT
|
GN
|
SOON
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.90 | 155.77 | 26.40 |
Price/Book Value | 6.40 | 1.53 | 6.01 |
Price/Sales | 2.92 | 1.22 | 4.38 |
Price/Cash Flow | 16.84 | 6.86 | 20.43 |
|
Metric
|
DEMANT
|
GN
|
SOON
|
|---|---|---|---|
Quick Ratio | 0.54 | 0.38 | 1.17 |
Current Ratio | 0.82 | 1.93 | 1.75 |
Interest Coverage | 6.70 | 0.18 | 23.14 |
|
Metric
|
DEMANT
|
GN
|
SOON
|
|---|---|---|---|
Return on Assets (Normalized) | 6.76% | −0.53% | 11.07% |
Return on Equity (Normalized) | 24.80% | −1.48% | 24.50% |
Return on Invested Capital (Normalized) | 9.75% | 0.50% | 16.97% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|!%y!$## | LOCK|vnC!w | $172B | |||
| Medtronic PLC
MDT
| LOCK|bg!P<&@ | LOCK|mycM$ | $113B | |||
| Stryker Corp
SYK
| LOCK|Dp<v@fHT | LOCK|!b | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|Pn>LF%q | LOCK|S^?Rw | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Xd@YsLC | LOCK|?gT! | $49B | |||
| DexCom Inc
DXCM
| LOCK|td%T>Jlv | LOCK|w%$s< | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|!G$Rxw> | LOCK|#N> | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|#f | LOCK|B$ | $24B | |||
| Steris PLC
STE
| LOCK|N%Zwl!q | LOCK|Y%>g | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|&Zx%?SbP | LOCK|XNL | $17B |
United States